Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02141269 · ClinicalTrials.gov registry record
Comparitive Effectiveness of PME Versus Transthoracic Echocardiogram (TTE)
A clinical trial, sponsored by Scripps Translational Science Institute.
- Completed
- Registry status
- 200
- Enrollment target
NCT02141269: Completed study, sponsored by Scripps Translational Science Institute.
NCT02141269 is a clinical trial that has completed, run by Scripps Translational Science Institute. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02141269 has completed, sponsored by Scripps Translational Science Institute.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
A new hand held pocket echo device (GE Vscan) has now become available to clinicians, with limited data available comparing the effectiveness of this device as a screening tool when compared to traditional transthoracic echocardiography (TTE). The investigators are evaluating the effectiveness of this hand-held echo (HHE) device in detecting cardiac pathology in a both an inpatient and outpatient clinical setting as compared to a comprehensive TTE evaluation.
Primary Outcome
Comparison of the two modalities includes accuracy, sensitivity, specificity, proportion visualized, and inter-observer variability.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2012-06 |
| Est. Completion | 2015-05 |
What the finished NCT02141269 record still lists
NCT02141269 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02141269 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02141269 about?
NCT02141269 is a clinical study titled "Comparitive Effectiveness of PME Versus Transthoracic Echocardiogram (TTE)". A new hand held pocket echo device (GE Vscan) has now become available to clinicians, with limited data available comparing the effectiveness of this device as a screening tool when compared to traditional transthoracic echocardiography (TTE). The investigators are evaluating the effectiveness of t...
What is the current status of trial NCT02141269?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2012-06. Estimated completion is 2015-05.
Who is sponsoring clinical trial NCT02141269?
This trial is sponsored by Scripps Translational Science Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia